Literature DB >> 9169288

Effect of topiramate on attention.

L A Burton1, C Harden.   

Abstract

Impaired attention is a frequently reported side effect of anti-epileptic medication, as well as a frequent general complaint of epilepsy. It is thus important to evaluate the effect of new medications on attention processes. Attention was assessed weekly in ten subjects receiving topiramate over a 3 month period. Attention was evaluated with digit span, a widely used index of attention. Different number sequences were constructed and randomized to allow for repeated use. Four of nine subjects showed significant correlations between topiramate dosage and forward digit span measured weekly, such that higher dosage was associated with poorer attention. The average topiramate dosage and seizure reduction did not differ between these subjects and those who did not show a significant relationship.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9169288     DOI: 10.1016/s0920-1211(96)01015-7

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  12 in total

Review 1.  Anticonvulsants and breast feeding: a critical review.

Authors:  B Bar-Oz; I Nulman; G Koren; S Ito
Journal:  Paediatr Drugs       Date:  2000 Mar-Apr       Impact factor: 3.022

Review 2.  Suicidality and antiepileptic drugs: is there a link?

Authors:  Vladimir V Kalinin
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

Review 3.  Newer anticonvulsants: comparative review of drug interactions and adverse effects.

Authors:  A Sabers; L Gram
Journal:  Drugs       Date:  2000-07       Impact factor: 9.546

4.  Effects of topiramate on cognitive function.

Authors:  P J Thompson; S A Baxendale; J S Duncan; J W Sander
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-11       Impact factor: 10.154

Review 5.  Antiepileptic drug-induced cognitive adverse effects: potential mechanisms and contributing factors.

Authors:  Marco Mula; Michael R Trimble
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

6.  Severity of Topiramate-Related Working Memory Impairment Is Modulated by Plasma Concentration and Working Memory Capacity.

Authors:  Samuel P Callisto; Sílvia M Illamola; Angela K Birnbaum; Christopher M Barkley; Sai Praneeth R Bathena; Ilo E Leppik; Susan E Marino
Journal:  J Clin Pharmacol       Date:  2020-04-16       Impact factor: 3.126

Review 7.  Topiramate. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in the management of epilepsy.

Authors:  H D Langtry; J C Gillis; R Davis
Journal:  Drugs       Date:  1997-11       Impact factor: 9.546

Review 8.  Topiramate and cognitive impairment: evidence and clinical implications.

Authors:  Marco Mula
Journal:  Ther Adv Drug Saf       Date:  2012-12

9.  Behavioral impairments in rats with chronic epilepsy suggest comorbidity between epilepsy and attention deficit/hyperactivity disorder.

Authors:  Eduardo Pineda; J David Jentsch; Don Shin; Grace Griesbach; Raman Sankar; Andrey Mazarati
Journal:  Epilepsy Behav       Date:  2013-11-18       Impact factor: 2.937

10.  Add-on Effect of Levetiracetam on Cognitive Activity of Carbamazepine and Topiramate Treated Healthy Rats.

Authors:  Priti Dhande; Satish Gonarkar; Dhara Sanghavi; Vijaya Pandit
Journal:  J Clin Diagn Res       Date:  2015-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.